• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

EPHB2

Kappa-opioid agonists are particularly efficacious in the treating peripheral pain but

January 18, 2019 by Katherine Lewis Leave a Comment

Kappa-opioid agonists are particularly efficacious in the treating peripheral pain but have problems with central anxious system (CNS)-mediated effects that limit their advancement. EC50 in the writhing assay was 0.032 mg/kg while no activity was detectable in the hotplate assay at dosages up to 30 mg/kg, indicating a peripheral selectivity VP-16 of 900-fold. We suggest … [Read more…]

Posted in: Blogging Tagged: EPHB2, VP-16

Purpose: To investigate a story DNA vaccination based upon reflection of

February 13, 2018 by Katherine Lewis Leave a Comment

Purpose: To investigate a story DNA vaccination based upon reflection of the HBV y antigen fused to a high temperature surprise proteins (HSP) simply because a strategy to enhance DNA vaccine efficiency. pCMV-HBe-HSP than that from pCMV-HBeAg immunized pets when triggered either with MHC classIor course II epitopes made from HBeAg (74% 9% 31% 6%, … [Read more…]

Posted in: Blogging Tagged: EPHB2, Pazopanib

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by